Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease

Cardiovascular Research

Volumn 69, Issue 4, 2006, Pages 899-907

  Goikoetxea, María J ^a   Beaumont, Javier ^a   González, Arantxa ^a   López, Begoña ^a   Querejeta, Ramón ^b   Larman, Mariano ^c   Díez, Javier ^a,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Division of Haemodynamics   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Heart failure; Hypertension; Hypertrophy; Isoforms; Peroxisome proliferator activated receptor

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3-HYDROXYACYL COA DEHYDROGENASES; AGED; APOPTOSIS; BLOTTING, WESTERN; CARNITINE O-PALMITOYLTRANSFERASE; ECHOCARDIOGRAPHY; ENDOCARDIUM; FEMALE; FIBROSIS; GENE EXPRESSION; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PPAR ALPHA; PROTEIN ISOFORMS; RETINOID X RECEPTOR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 32444433977     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.11.016     Document Type: Article

References (36)

1. M.E. Christe, and R.L. Rodgers Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat J Mol Cell Cardiol 26 1994 1371 1375
2. T. Hajri, A. Ibrahimi, C.T. Coburn, F.F. Knapp Jr., T. Kurtz, and M. Pravenec Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy J Biol Chem 276 2001 23661 23666
3. L. de las Fuentes, P. Herrero, L.R. Peterson, D.P. Kelly, R.J. Gropler, and V.G. Davila-Roman Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease Hypertension 41 2003 83 87
4. M.N. Sack, T.A. Rader, S. Park, J. Bastin, S.A. McCune, and D.P. Kelly Fatty acid oxidation enzyme gene expression is downregulated in the failing heart Circulation 94 1996 2837 2842
5. K. Watanabe, H. Fujii, T. Takahashi, M. Kodama, Y. Aizawa, and Y. Ohta Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity J Biol Chem 275 2000 22293 22299
6. B.N. Finck, and D.P. Kelly Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart J Mol Cell Cardiol 34 2002 1249 1257
7. M. Iglarz, R.M. Touyz, E.C. Viel, P. Paradis, F. Amiri, and Q.N. Diep Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension Hypertension 42 2003 737 743
8. Q.N. Diep, K. Benkirane, F. Amiri, J.S. Cohn, D. Endemann, and E.L. Schiffrin PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats J Mol Cell Cardiol 36 2004 295 304
9. T. Ogata, T. Miyauchi, S. Sakai, Y. Irukayama-Tomobe, K. Goto, and I. Yamaguchi Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts Clin Sci (Lond) 103 2002 284S 288S
10. T. Ogata, T. Miyauchi, S. Sakai, M. Takanashi, Y. Irukayama-Tomobe, and I. Yamaguchi Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway J Am Coll Cardiol 43 2004 1481 1488
11. J.D. Tugwood, T.C. Aldridge, K.G. Lambe, N. Macdonald, and N.J. Woodyatt Peroxisome proliferator-activated receptors: structures and function Ann NY Acad Sci 804 1996 252 265
12. C.N. Palmer, M.H. Hsu, K.J. Griffin, J.L. Raucy, and E.F. Johnson Peroxisome proliferator activated receptor-alpha expression in human liver Mol Pharmacol 53 1998 14 22
13. J.C. Hanselman, M.A. Vartanian, B.P. Koester, S.A. Gray, A.D. Essenburg, and T.J. Rea Expression of the mRNA encoding truncated PPAR alpha does not correlate with hepatic insensitivity to peroxisome proliferators Mol Cell Biochem 217 2001 91 97
14. P. Gervois, I.P. Torra, G. Chinetti, T. Grotzinger, G. Dubois, and J.C. Fruchart A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity Mol Endocrinol 13 1999 1535 1549
15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
16. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 1993 6A 13A
17. R.N. Doughty, G.A. Whalley, G. Gamble, S. MacMahon, and N. Sharpe Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group J Am Coll Cardiol 29 1997 1060 1066
18. R. Querejeta, N. Varo, B. Lopez, M. Larman, E. Artinano, and J.C. Etayo Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease Circulation 101 2000 1729 1735
19. A. Ganau, R.B. Devereux, M.J. Roman, G. de Simone, T.G. Pickering, and P.S. Saba Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension J Am Coll Cardiol 19 1992 1550 1558
20. M.A. Quinones, E. Pickering, and J.K. Alexander Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume Chest 74 1978 59 65
21. F. Sanger, S. Nicklen, and A.R. Coulson DNA sequencing with chain-terminating inhibitors Biotechnology 24 1992 104 108
22. T. Sher, H.F. Yi, O.W. McBride, and F.J. Gonzalez cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 32 1993 5598 5604
23. P.M. Barger, and D.P. Kelly PPAR signaling in the control of cardiac energy metabolism Trends Cardiovasc Med 10 2000 238 245
24. A. González, B. López, and S. Ravassa Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II Hypertension 39 2002 75 80
25. H.G. Y.B. Burkitt, and J.W. Heath Wheater's functional histology 1996 Churchill Livingstone Edinburgh
26. P.G. Zaphiropoulos Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis Mol Cell Biol 17 1997 2985 2993
27. P.M. Barger, J.M. Brandt, T.C. Leone, C.J. Weinheimer, and D.P. Kelly Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth J Clin Invest 105 2000 1723 1730
28. M.E. Young, F.A. Laws, G.W. Goodwin, and H. Taegtmeyer Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart J Biol Chem 276 2001 44390 44395
29. J. Karbowska, Z. Kochan, and R.T. Smolenski Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart Cell Mol Biol Lett 8 2003 49 53
30. R.H. Oakley, M. Sar, and J.A. Cidlowski The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function J Biol Chem 271 1996 9550 9559
31. R.J. Koenig, M.A. Lazar, R.A. Hodin, G.A. Brent, P.R. Larsen, and W.W. Chin Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing Nature 337 1989 659 661
32. A.E. Bielawska, J.P. Shapiro, and L. Jiang Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion Am J Pathol 151 1997 1257 1263
33. M.A. Fortuño, A. González, S. Ravassa, B. López, and J. Díez Clinical implications of apoptosis in hypertensive heart disease Am J Physiol Heart Circ Physiol 284 2003 H1495 H1506
34. A. González, M.A. Fortuño, R. Querejeta, S. Ravassa, B. Lopez, and N. Lopez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res 59 2003 549 562
35. V. da Cunha, D.M. Tham, B. Martin-McNulty, G. Deng, J.J. Ho, and D.W. Wilson Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation Atherosclerosis 178 2005 9 17
36. E.S. Pearlman, K.T. Weber, J.S. Janicki, G.G. Pietra, and A.P. Fishman Muscle fiber orientation and connective tissue content in the hypertrophied human heart Lab Invest 46 1982 158 164